Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

MIRO | Miromatrix Medical Inc

Index	-	P/E	-	EPS (ttm)	-1.27	Insider Own	24.38%	Shs Outstand	20.94M	Perf Week	-0.74%
Market Cap	36.87M	Forward P/E	-	EPS next Y	-0.69	Insider Trans	3.50%	Shs Float	20.65M	Perf Month	8.00%
Income	-28.58M	PEG	-	EPS next Q	-0.21	Inst Own	23.62%	Short Float / Ratio	2.47% / 22.10	Perf Quarter	-27.03%
Sales	0.96M	P/S	38.40	EPS this Y	33.10%	Inst Trans	6.44%	Short Interest	0.51M	Perf Half Y	-11.76%
Book/sh	0.79	P/B	1.71	EPS next Y	28.35%	ROA	-75.12%	Target Price	15.00	Perf Year	-62.08%
Cash/sh	0.78	P/C	1.74	EPS next 5Y	-	ROE	-92.87%	52W Range	0.91 - 4.50	Perf YTD	-54.85%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-116.91%	52W High	-70.00%	Beta	0.45
Dividend %	-	Quick Ratio	5.63	Sales past 5Y	891.07%	Gross Margin	-72.14%	52W Low	48.92%	ATR	0.13
Employees	76	Current Ratio	5.63	Sales Q/Q	115.51%	Oper. Margin	-3098.65%	RSI (14)	47.95	Volatility	8.15% 9.56%
Optionable	Yes	Debt/Eq	0.15	EPS Q/Q	39.63%	Profit Margin	-2979.90%	Rel Volume	0.15	Prev Close	1.35
Shortable	Yes	LT Debt/Eq	0.13	Earnings	Aug 14 AMC	Payout	-	Avg Volume	23.09K	Price	1.35
Recom	1.00	SMA20	-2.69%	SMA50	-5.10%	SMA200	-30.43%	Volume	1,985	Change	0.00%

Sep-06-23 04:01PM	Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference (GlobeNewswire) -9.27%
Sep-05-23 04:04PM	Miromatrix Announces Participation in the ARM Tissue Engineering and Therapeutics Workshop (GlobeNewswire) +9.42%
Aug-21-23 09:51AM	Miromatrix Medical Inc. (NASDAQ:MIRO) Q2 2023 Earnings Call Transcript (Insider Monkey) -15.60%
Aug-15-23 07:30AM	Q2 2023 Miromatrix Medical Inc Earnings Call (Thomson Reuters StreetEvents) +6.29%
Aug-14-23 04:01PM	Miromatrix Reports Second Quarter 2023 Results and Provides Corporate Update (GlobeNewswire) -5.47%
04:01PM	Loading…
Jul-25-23 04:01PM	Miromatrix to Report Second Quarter 2023 Financial Results (GlobeNewswire)
Jul-17-23 07:09AM	Companies Like Miromatrix Medical (NASDAQ:MIRO) Could Be Quite Risky (Simply Wall St.)
Jul-13-23 04:01PM	Miromatrix Poster Voted Best in Congress at the 2023 American Transplant Congress; Jack Lake Wins Lifetime Achievement Award (GlobeNewswire) +7.18%
Jun-01-23 04:01PM	Miromatrix Announces CEO Jeff Ross, Ph.D. will Expand His Role by Resuming Leadership of R&D (GlobeNewswire)
May-30-23 04:08PM	Miromatrix Presenting at the 2023 American Transplant Congress (GlobeNewswire)
04:05PM	Miromatrix Announces Participation in the 20th Annual Craig-Hallum Institutional Investor Conference (GlobeNewswire)
May-11-23 05:45PM	Miromatrix Medical Inc. (MIRO) Reports Q1 Loss, Misses Revenue Estimates (Zacks)
04:01PM	Miromatrix Reports First Quarter 2023 Results and Provides Corporate Update (GlobeNewswire)
Apr-27-23 06:00PM	Miromatrix to Report First Quarter 2023 Financial Results (GlobeNewswire)
Apr-10-23 07:01AM	Miromatrix CEO Jeff Ross to Present at the 2023 Cell & Gene Meeting on the Med (GlobeNewswire)
06:55AM	Loading…
Apr-05-23 06:55AM	CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation (Business Wire)
06:50AM	CareDx and Miromatrix Announce Exclusive Partnership to Advance Research Using Bioengineered Organs for Human Transplantation (GlobeNewswire)
Apr-03-23 06:27AM	Multiple insiders bought Miromatrix Medical Inc. (NASDAQ:MIRO) stock earlier this year, a positive sign for shareholders (Simply Wall St.) -6.55%
Mar-31-23 05:15PM	Miromatrix Medical Inc. (MIRO) Reports Q4 Loss, Tops Revenue Estimates (Zacks) +12.75%
04:01PM	Miromatrix Reports Fourth Quarter and Full Year 2022 Results and Provides Corporate Update (GlobeNewswire)
Mar-15-23 04:01PM	Miromatrix to Report Fourth Quarter and Full Year 2022 Financial Results (GlobeNewswire) -9.38%
Mar-07-23 08:35PM	Miromatrix Medical Inc. Announces Pricing of $10 Million Public Offering of Common Stock (GlobeNewswire) -5.73%
06:40PM	Why Miromatrix Medical Shares Are Getting Obliterated After Hours (Benzinga)
04:01PM	Miromatrix Medical Inc. Announces Proposed Public Offering of Common Stock (GlobeNewswire)
Mar-06-23 08:15AM	Stoke Therapeutics, Inc. (STOK) Reports Q4 Loss, Tops Revenue Estimates (Zacks)
Feb-06-23 06:52AM	Companies Like Miromatrix Medical (NASDAQ:MIRO) Could Be Quite Risky (Simply Wall St.)
Feb-01-23 08:00AM	Miromatrix and Baxter Announce Collaborative Research Agreement Aiming to Advance Care for Patients with Acute Liver Failure (GlobeNewswire) -10.32%
07:59AM	Miromatrix Provides Update on miroliverELAP (GlobeNewswire)
Dec-15-22 09:10AM	FDA Slaps Clinical Hold On Miromatrix's For Bioengineered Liver Platform (Benzinga) -30.24%
08:35AM	Miromatrix's stock is down 33% (MarketWatch)
05:30PM	Loading…
Dec-14-22 05:30PM	Miromatrix Announces FDA Clinical Hold on IND Application for miroliverELAP (GlobeNewswire)
Nov-21-22 07:01AM	Miromatrix Announces Participation in the Piper Sandler 34th Annual Healthcare Conference (GlobeNewswire)
Nov-17-22 05:02AM	Miromatrix Medical Third Quarter 2022 Earnings: Beats Expectations (Simply Wall St.)
Nov-14-22 04:01PM	Miromatrix Reports Filing of IND, Third Quarter 2022 Results, and Provides Corporate Update (GlobeNewswire)
Nov-09-22 08:25AM	ProQR (PRQR) Reports Q3 Loss, Lags Revenue Estimates (Zacks)
Nov-08-22 03:40PM	Sidoti's November Micro-Cap Virtual Conference (ACCESSWIRE)
Nov-03-22 04:01PM	Miromatrix to Report Third Quarter 2022 Financial Results (GlobeNewswire)
Oct-19-22 07:00AM	Miromatrix CEO Jeff Ross Delivering Keynote Address at ARMI \| BioFabUSA 2022 Fall Summit: Meeting in the Millyard (GlobeNewswire)
Oct-05-22 04:01PM	Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Mesa (GlobeNewswire) -6.65%
Sep-26-22 04:01PM	Miromatrix CEO Jeff Ross to Present at the Innovations in Solid Organ and Hematopoietic Stem Cell Transplant Virtual Event (GlobeNewswire) +5.35%
Sep-20-22 04:01PM	Miromatrix CEO Jeff Ross to Present at the Bioregate European Regenerative Medicine Forum (GlobeNewswire)
Sep-10-22 08:47AM	Institutions own 18% of Miromatrix Medical Inc. (NASDAQ:MIRO) shares but individual investors control 52% of the company (Simply Wall St.)
Aug-25-22 07:00AM	Miromatrix Receives New Patent for Its Novel Perfusion Decellularization and Recellularization Technology (GlobeNewswire)
Aug-23-22 07:00AM	Miromatrix Announces Participation in Upcoming Gilmartin Emerging Growth Company Showcase (GlobeNewswire)
Aug-15-22 04:01PM	Miromatrix Reports Second Quarter 2022 Results and Provides Corporate Update (GlobeNewswire)
Aug-10-22 07:00AM	Miromatrix Appoints Jack Lake, M.D., as Medical Director (GlobeNewswire)
Aug-01-22 04:01PM	Miromatrix to Report Second Quarter 2022 Financial Results (GlobeNewswire)
Jul-11-22 07:00AM	Axogen, Inc. Appoints William Burke to Board of Directors (GlobeNewswire)
Jul-05-22 07:01AM	Miromatrix Applauds the FDA for Its Continued Commitment to the Field of Organ Transplant (GlobeNewswire) -14.37%
May-31-22 04:30PM	Miromatrix Announces Participation in the 2022 American Transplant Congress (GlobeNewswire)
May-25-22 04:30PM	Miromatrix Announces Participation in the 19th Annual Craig-Hallum Institutional Investor Conference (GlobeNewswire) -5.25%
May-17-22 04:39PM	Miromatrix Announces Participation in H.C. Wainwright Global Investment Conference (GlobeNewswire)
May-16-22 04:01PM	Miromatrix Reports First Quarter 2022 Results and Provides Corporate Update (GlobeNewswire)
Apr-28-22 04:01PM	Miromatrix to Report First Quarter 2022 Financial Results (GlobeNewswire) +5.42%
Apr-19-22 07:00AM	Miromatrix CEO Jeff Ross to Present at the 2022 Cell & Gene Meeting on the Med (GlobeNewswire) +5.07%
Mar-30-22 04:01PM	Miromatrix Reports Fourth Quarter and Full Year 2021 Results and Provides Corporate Update (GlobeNewswire)
07:15AM	Miromatrix moves into new headquarters, adding production capacity for bioengineered organs (American City Business Journals)
Mar-29-22 07:00AM	Miromatrix Moves into New Headquarters Complete with In-House Manufacturing Capabilities (GlobeNewswire) -7.00%
Mar-17-22 04:01PM	Miromatrix to Report Fourth Quarter and Full Year 2021 Financial Results (GlobeNewswire)
Mar-16-22 04:01PM	Miromatrix to Participate in CareDxs Xenotransplantation Innovation Day (GlobeNewswire) +11.33%
Mar-01-22 05:15PM	Miromatrix Names Jim Douglas as New Chief Financial Officer (GlobeNewswire)
Feb-10-22 07:00AM	Miromatrix to Ring Nasdaq Closing Bell on National Donor Day, February 14, 2022 (GlobeNewswire) +7.59%
Feb-01-22 07:00AM	Miromatrix Announces Participation in BTIG MedTech, Digital Health, Life Science & Diagnostic Tools Conference (GlobeNewswire)
Jan-06-22 04:46PM	Miromatrix adds Lisa Wipperman Heine, William Burke to board (American City Business Journals)
Jan-05-22 07:00AM	Miromatrix Announces Two New Board Members (GlobeNewswire)
Dec-17-21 07:00AM	Miromatrix Submits Pre-IND Request to the FDA for Its External Liver Assist Product to Treat Acute Liver Failure (GlobeNewswire) -11.49%
Nov-15-21 04:01PM	Miromatrix Reports Third Quarter 2021 Results (GlobeNewswire)
Oct-28-21 04:01PM	Miromatrix to Report Third Quarter 2021 Financial Results (GlobeNewswire)
Oct-12-21 03:57PM	Miromatrix hits clinical milestone on path to scale organ transplants (American City Business Journals)
Oct-07-21 05:30AM	Miromatrix Announces the First Successful Transplant of a Bioengineered Whole Organ in a Large Animal (GlobeNewswire)
Sep-24-21 09:52AM	What Kind Of Shareholders Hold The Majority In Miromatrix Medical Inc.'s (NASDAQ:MIRO) Shares? (Simply Wall St.)
Sep-20-21 07:00AM	Miromatrix Medical Added to Russell Microcap® Index (GlobeNewswire)
Sep-09-21 08:00AM	Miromatrix Welcomes Dr. John Barry as Vice President of Research and Development (GlobeNewswire)
Aug-11-21 07:00AM	Miromatrix Announces Key Strategic Investors to Advance the Development of Bioengineered Livers and Kidneys (GlobeNewswire)
Jun-28-21 04:01PM	Miromatrix Medical Announces Closing of Initial Public Offering (GlobeNewswire)
Jun-24-21 07:00AM	Miromatrix Medical Announces Pricing of Upsized Initial Public Offering (GlobeNewswire)

Miromatrix Medical, Inc. operates as a biotechnology company, which engages in the development of biological human organs to solve the chronic shortage of transplantable organs. It offers perfusion decellularization and recellularization technology, as well as organ-derived biological products such as MIROMESH and MIRODERM for soft tissue reinforcement and advanced wound care. The company was founded in 2009 by Doris A. Taylor and Cohen Robert and is headquartered in Eden Prairie, MN.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
ERB JOHN L	Director	Mar 10	Buy	1.60	31,250	50,000	56,260	Mar 30 04:57 PM
Heine Lisa Wipperman	Director	Mar 10	Buy	1.60	31,250	50,000	80,155	Mar 30 04:56 PM
Burke William P. Mr.	Director	Mar 10	Buy	1.60	31,250	50,000	80,155	Mar 30 04:57 PM
Douglas James Michael	CHIEF FINANCIAL OFFICER	Mar 10	Buy	1.60	31,250	50,000	51,250	Mar 30 05:01 PM
Ross Jeffrey James	CHIEF EXECUTIVE OFFICER	Mar 10	Buy	1.60	31,250	50,000	396,276	Mar 30 05:00 PM
Maag Peter	Director	Mar 10	Buy	1.60	31,250	50,000	66,259	Mar 30 04:58 PM
BUCKMAN PAUL	Director	Mar 10	Buy	1.60	31,250	50,000	52,593	Mar 30 04:59 PM
Barry John Joseph	VICE PRESIDENT OF R&D	Mar 10	Buy	1.60	6,250	10,000	35,485	Mar 30 04:59 PM
Ross Jeffrey James	CHIEF EXECUTIVE OFFICER	Dec 06	Option Exercise	1.25	37,500	46,875	331,088	Dec 08 05:34 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

MIRO | Miromatrix Medical Inc

Upgrade your FINVIZ experience